Antimicrobial Susceptibility Testing Market to be Dominated by the Emergence of Antibiotic-Restraint Strains through 2028
Growing advancements in
antimicrobial susceptibility testing (AST) technology and various initiatives
taken by government to improve the healthcare infrastructure of their
respective country are the major drivers for the global antimicrobial
susceptibility testing market.
According to TechSci Research
report, “Global Antimicrobial Susceptibility Testing Market –Industry
Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028”, the
global antimicrobial susceptibility testing market is anticipated to register a
high CAGR during the forecast period. This can be ascribed to increase in
prevalence of certain hospital acquired diseases across the world in forecast
period.
Antimicrobial susceptibility
testing (AST) is a laboratory technique used to determine the effectiveness of
antibiotics against specific microorganisms. As antibiotic resistance is
becoming more prevalent, the need for accurate and rapid antimicrobial
susceptibility testing is also increasing. For instance, methicillin-resistant
staphylococcus aureus (MRSA) is a strain of bacteria which is commonly used to
treat staph infections. The emergence of MRSA was driven by the widespread use
of antibiotics, particularly methicillin, which created selective pressure for
the bacteria to evolve resistance. To address the problem of
antibiotic-resistant bacteria such as MRSA, healthcare providers are
implementing strategies to reduce antibiotic use and prevent the spread of
infection by being more inclined towards antimicrobial susceptibility testing
which is further expected to register a lucrative growth to global
antimicrobial susceptibility testing market in the forecast period. Increase in
advancements associated with antimicrobial susceptibility testing technology is
also one of the major factors leading to growth of global antimicrobial
susceptibility testing market. For instance, the Accelerate Pheno system which
is helpful in identification and antimicrobial susceptibility testing of
pathogens in positive blood culture is making use of automated fluorescence in
situ hybridization technology with morphokinetic cellular analysis. This
provides rapid species identification (ID) and antimicrobial susceptibility
testing (AST) results for the most identified organisms in bloodstream
infections. Moreover, increase in occurrence of hospital acquired diseases
across different parts of the world is also expected to propel the growth of
global antimicrobial susceptibility testing market in the forecast period.
Urinary tract infections (UTI), surgical site infections (SSI), bloodstream
infections, pneumonia, clostridium difficile infection (CDI), and
methicillin-resistant staphylococcus aureus (MRSA) are some of the common
infections which are acquired by patients during receiving treatment in a
healthcare facility such as a hospital or clinic. According to the
report published by Patient Care Link on Healthcare-Acquired Infections (HAIs)
in 2022, it has been observed that in American hospitals alone, the Centers for
Disease Control (CDC) estimates that HAIs account for an estimated 1.7 million
infections and 99,000 associated deaths each year. 32% cases of all
healthcare-acquired infection accounted for urinary tract infections, followed
by 22% cases of surgical site infections, 15% cases of pneumonia (lung
infections), and 14% cases of bloodstream infections. Emergence of
these infections is further increasing the demand of antimicrobial
susceptibility testing in the market for early prevention and treatment at
primary stage. Furthermore, various initiatives taken by the government of
individual country to make antimicrobial susceptibility testing more affordable
for people is also projected to register an impressive growth to global
antimicrobial susceptibility testing market in the forecast period. Moreover,
governments are providing funding for research and development of new AST
products and technologies. For instance, the UK government has allocated EUR 10
million to fund research on new AST technologies to tackle antimicrobial
resistance (AMR). The US government is also providing funding through the
National Institutes of Health (NIH) and the Biomedical Advanced Research and
Development Authority (BARDA) to develop new AST products.
However, complex regulatory
framework for antimicrobial susceptibility testing and high cost of automated
laboratory infrastructure are expected to slow down the growth of the market in
the coming years.
Browse over XX Market
Data Figures and spread through XX Pages and an in-depth TOC on "global
antimicrobial susceptibility testing market.”
The global antimicrobial
susceptibility testing market segmentation is based on product, technique,
application, end user, company, and region.
Based on product, the market is
further divided into manual tests, (mic strips, susceptibility testing disks,
susceptibility plates), automated instruments, and consumables & media.
Manual tests are likely to dominate the market in the forecast period. This can
be ascribed to its ease of availability and lower cost as compared to automated
testing in the market.
Some of the major companies
operating in the global antimicrobial susceptibility testing market include:
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- bioMerieux, Inc.
- Creative Diagnostics
- Hi-Media Laboratories Pvt. Ltd.
- PerkinElmer, Inc.
- ELITech Group SAS
- Hoffmann-La Roche Ltd.
- Accelerate Diagnostics, Inc.
Download Free Sample Report
Customers can also request for
10% free customization on this report.
“Certain regions are expected to
dominate the demand for antimicrobial susceptibility testing in the world.
Growing use of commercial rapid testing systems for fungal analysis increasing
public and private investments for improving the quality of antimicrobial
susceptibility testing in the market is expected to register a lucrative growth
to global antimicrobial susceptibility testing market in the forecast
period," said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based global management consulting firm.
“Antimicrobial Susceptibility
Testing Market - Global Industry Size, Share, Trends, Competition, Opportunity,
and Forecast, 2018-2028, Segmented By
Product (Manual Tests, (MIC Strips, Susceptibility Testing Disks,
Susceptibility Plates) Automated Instruments, and Consumables & Media), By
Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, and
Others), By Application (Drug Development, Susceptibility Testing, and Others),
By End User (Hospitals, Diagnostic Laboratories, BioTechnique &
Pharmaceutical Companies, and Others), By Region and Competition”, has
evaluated the future growth potential of global antimicrobial susceptibility
testing market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide innovative
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global antimicrobial
susceptibility testing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com